Pathogenesis of autoimmune disease Flashcards

1
Q

What is rheumatoid arthritis?

A

Chronic joint inflammation that can result in joint damage - site of inflammation is the synovium: chronic synovitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is rheumatoid arthritis associated to?

A

Autoantibodies

  • Rheumatoid factor
  • Anti-cyclic citrullinated peptide (CCP) antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is ankylosing spondylitis?

A

Chronic spinal inflammation that can result in spinal fusion and deformity - site of inflammation is the enthesis (anulus fibrosus)

Spinal deformities include increased thoracic kyphosis and loss of the normal lumbar lordosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List some seronegative spondyloarthropathies?

A

Seronegative - No autoantibodies

  • Ankylosing spondylitis
  • Reiters syndrome and REACTIVE ARTHRITIS
  • Arthritis associated with psoriasis (psoriatic arthritis)
  • Arthritis associated with gastrointestinal inflammation (enteropathic synovitis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is systemic lupus erythematosus (SLE)?

A

Chronic tissue inflammation in the presence of antibodies directed against self antigens - multi site inflammation but particularly the joints, skin and kidney

Immune complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is SLE associated to?

A

Autoantibodies:

  • antinuclear antibodies
  • anti-double stranded DNA antibodies

( - Anti-cardiolipin antibodies
also termed anti-phospholipid antibodies and associated with risk of arterial and venous thrombosis in SLE; may also occur in absence of SLE in what is termed the ‘primary anti-phospholipid antibody syndrome’)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What MHCs are associated with RA, SLE and AS?

A
RA = HLA-DR4
SLE = HLA-DR3
AS = HLA-B27
The genes within the MHC class I (B) and class II (DR) regions encode cell surface proteins
These were first recognised on human white cells – hence termed human leucocyte antigens (‘HLA’)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the function of MHC class I & II molecules?

A

They present antigens to T cells.

Draw table

E.g. antigen and HLA-B27 triggers CD8 +ve T cell response in Ankylosing Spondylitis
E.g. antigen and HLA-DR4 triggers CD4 +ve T cell response in Rheumatoid Arthritis

The antigen is peptide that can be exogenous or self.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

?

A

?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which diseases have autoantibodies?

A

Rheumatoid arthritis - RF, anti CCP antibody

Systemic Lupus - ANA, anti-dsDNA antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the autoantibodies in SLE?

A

ANA - Seen in all SLE cases, not specific for SLE
Anti-dsDNA - Specific for SLE. Serum level of antibody correlates with disease activity.
anti-cardiolipin antibodies - associated with risk of arterial and venous thrombosis in SLE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does a sick lupus patient commonly have?

A

Low complement levels - because they have been used to cause inflammation.

High serum levels of anti-ds-DNA antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the current understanding of the pathogenesis of systemic lupus erythematosus?

A

Main point = causes apoptosis

1) Apoptosis leads to translocation of nuclear antigens to membrane surface
2) Impaired clearance of apoptotic cells results in enhanced presentation of nuclear antigens to immune cells
3) B cell autoimmunity
4) Tissue damage by antibody effector mechanisms e.g. complement activation and Fc receptor engagement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the different cytokines in rheumatology?

A

See slides

  • CD4 +ve T helper cell subsets include: Th1, Th2 and Th17
    1) Th1 cells secrete IL-2 and γ-IFN and response is important in CD8 +ve cytotoxicity and macrophage stimulation
    2) Th2 cells secrete IL-4 (IgE responses), IL-5 (eosinophils), IL-6 (B cells to plasma cells) and IL-10 (inhibit macrophage response)
    3) Th17 cells develop in response to IL-23 and secrete IL-17, a potent cytokine which triggers IL-6, IL-8, TNFα, matrix metalloproteinases and RANKL in target cells. Important in mucosal immunity but also in disease including arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is TNF-alpha?

A

The cytokine tumour necrosis factor-alpha (TNFα) is the dominant pro-inflammatory cytokine in the rheumatoid synovium and its pleotropic actions are detrimental. Therefore it is a target for treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the function of RANKL?

A

It is important in bone destruction in rheumatoid arthritis. It is produced by T cells and synovial fibroblasts in rheumatoid arthritis. Acts to stimulate osteoclast formation (osteoclastogenesis)

It binds to ligand on osteoclast precursors (RANK)

17
Q

What is RANKL upregulated by?

A
  • Interleukin-1, TNF-alpha
  • Interleukin-17 - potent action on osteoclastogenesis via RANKL-RANK pathway
  • PTH-related peptide
18
Q

What antagonizes the action of RANKL?

A

Decoy receptor - osteoprotegerin (OPG)

19
Q

What drug is used against RANKL?

A

Denosumab - Monoclonal antibodies against RANKL: indicated for treatment of osteoporosis, bone metastases, multiple myeloma and Giant cell tumours

20
Q

What can be used to treat SLE?

A

B cell hyper-reactivity is a key feature of SLE

Rituximab – a chimeric anti-CD20 antibody used to deplete B cells

Belimumab - a monoclonal antibody against a B cell survival factor call BLYS

21
Q

Describe belimumab?

A

Recombinant fully human IgG1 monoclonal antibody against BLYS (also termed BAFF)

BAFF = B cell activating factor of the tumour necrosis factor family
BLYS = B-lymphocyte stimulator

Inhibits activity of BAFF resulting in impaired B cell survival and reduced B cell numbers

(you don’t really need to know it)

22
Q

What are prostaglandins?

A

Lipid mediators of inflammation that act on platelets, endothelium, uterine tissue and mast cells. They are synthesised from essential fatty acids

Phospholipase A2 –> Generates arachidonic acid from diacylglycerol in cell membranes. Arachidonic acid can enter two pathways.

1) Cyclooxygenase pathway: Prostaglandins
2) Lipooxygenase pathway: Leukotrienes

See slides

23
Q

What drugs are used to counteract the effects of prostaglandins?

A

1) Glucocorticoids inhibit phospholipase A2

2) Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (‘COX inhibition’)
- Benefits: analgesia, anti-pyretic, anti-inflammatory and anti-platelet (thromboxane A2)
- Unwanted effects: e.g. asthma exacerbation, gastro-intestinal ulcers, thrombosis, liver and renal problems

They don’t help with bone damage
Don’t focus too much on management